June 04, 2025 a 03:43 pm
BDX: Fundamental Ratio Analysis - Becton, Dickinson and Company
Becton, Dickinson and Company (BDX) is a prominent player in the healthcare industry, providing a wide array of medical supplies and diagnostic products worldwide. As a pioneer in medical technology, BDX shows stability in its stock performance. This analysis will delve into the fundamental aspects and provide insights on the company's financial health and market position.
Fundamental Rating
Becton, Dickinson and Company maintains a solid footing in the market, demonstrated by its overall financial performance and fundamental ratios.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 4 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 2 |
Historical Rating
The historical performance showcases a slight improvement in scores, reflecting BDX's commitment to maintaining its market position.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-06-03 | 3 | 5 | 4 | 4 | 1 | 1 | 2 |
| Previous | 0 | 5 | 4 | 4 | 1 | 1 | 2 |
Analyst Price Targets
Analysts have a positive outlook, with consistent price targets indicating stability in future price potential.
| High | Low | Median | Consensus |
|---|---|---|---|
| 260 | 260 | 260 | Buy |
Analyst Sentiment
Analyst sentiment suggests a consensus towards buying, with a notable proportion of recommendations being in favor.
| Recommendation | Count | Percentage |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 17 | |
| Hold | 14 | |
| Sell | 0 | |
| Strong Sell | 0 |
Conclusion
Becton, Dickinson and Company is positioned well within the healthcare sector, demonstrating robust performance metrics. The company offers a stable investment opportunity, underscored by positive analyst sentiment and consistent price targets. While the debt to equity ratio suggests leverage, the overall strategic outlook remains sound. Investors may anticipate growth, supported by the firm's extensive product range and global presence. However, cautious observation of financial liabilities and market dynamics is advised.